Search results for "Vaccinations"
Panel ponders postacute sequelae of COVID-19
The consequences of postacute sequelae of COVID-19 have led to research into this emerging condition.
https://immattersacp.org/archives/2021/07/panel-ponders-postacute-sequelae-of-covid-19.htm
1 Jul 2021
Pacemakers, stents recalled; warnings on liver disease drug
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2021/07/pacemakers-stents-recalled-warnings-on-liver-disease-drug.htm
1 Jul 2021
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021
ACP issues policy statement on global COVID-19 vaccine distribution and allocation
The College's statement stresses that physicians have a responsibility to advocate for the health and well-being of patients and communities locally and globally and calls for a coordinated global vaccination effort to be ethical as well as practical.
https://immattersacp.org/weekly/archives/2021/06/22/2.htm
22 Jun 2021
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021
Handling hoarseness, hearing problems in primary care
Internists can help patients cope with common ENT conditions like hoarseness, tinnitus, and hearing loss.
https://immattersacp.org/archives/2021/06/handling-hoarseness-hearing-problems-in-primary-care.htm
1 Jun 2021
New research adds to data on symptoms after COVID-19, vaccines' effects
Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
https://immattersacp.org/weekly/archives/2021/05/25/1.htm
25 May 2021
Studies assess responses, reactions to vaccines; long-term effects of COVID-19 infection
Recent COVID-19 vaccine studies showed good response in pregnant women, as well as possible localized rashes from the Moderna vaccine. Analyses of ICU patients and those treated at a post-COVID-19 clinic highlighted the long-term effects of the virus, and a study found that dialysis patients maintained antibodies six months after COVID-19 infection.
https://immattersacp.org/weekly/archives/2021/05/18/1.htm
18 May 2021
Many recent studies reporting on COVID-19 vaccines' safety, effectiveness
New studies looked at the safety of the adenovirus COVID-19 vaccines, the effectiveness of almost all the vaccines, and the impacts of COVID-19 infection in pregnancy and on long-term cardiac function. A physician columnist addressed pandemic-related anger.
https://immattersacp.org/weekly/archives/2021/05/11/1.htm
11 May 2021
Clot concerns with adenovirus COVID-19 vaccines, antibody treatment recommendations and data
Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23. The NIH updated its recommendations on monoclonal antibody treatments for outpatients.
https://immattersacp.org/weekly/archives/2021/04/20/1.htm
20 Apr 2021